Improved in vivo Experimental Screening Identifies an Anabolic Analog of 1,25 Dihydroxyvitamin D3 With Minimal Bone Resorption Activity
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 06, 2020
- Source ID
- 10.1002/jbmr.3933
Entities
People
- Laura M. Calvi
Organizations
- United States Department of Defense